Gregory J. Tryder

Array ( [id] => 4840611 [patent_doc_number] => 20080281097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Process for Preparing an Angiotensin II Receptor Antagonist' [patent_app_type] => utility [patent_app_number] => 11/997715 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6101 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20080281097.pdf [firstpage_image] =>[orig_patent_app_number] => 11997715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279548 [patent_doc_number] => 20090131680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'PROCESS FOR THE PREPARATION OF OLMESARTAN MEDOXOMIL' [patent_app_type] => utility [patent_app_number] => 11/997133 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7709 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131680.pdf [firstpage_image] =>[orig_patent_app_number] => 11997133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 42923 [patent_doc_number] => 07781462 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-24 [patent_title] => 'Compounds for the treatment of proliferative disorders' [patent_app_type] => utility [patent_app_number] => 11/492692 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46828 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/781/07781462.pdf [firstpage_image] =>[orig_patent_app_number] => 11492692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 84210 [patent_doc_number] => 07741507 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Process for preparing Valsartan' [patent_app_type] => utility [patent_app_number] => 11/491638 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3177 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741507.pdf [firstpage_image] =>[orig_patent_app_number] => 11491638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270676 [patent_doc_number] => 07563912 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of Levetiracetam and analogues' [patent_app_type] => utility [patent_app_number] => 11/488073 [patent_app_country] => US [patent_app_date] => 2006-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8514 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563912.pdf [firstpage_image] =>[orig_patent_app_number] => 11488073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873953 [patent_doc_number] => 20080200687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Preparation of Terazole Derivatives' [patent_app_type] => utility [patent_app_number] => 11/995862 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13719 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200687.pdf [firstpage_image] =>[orig_patent_app_number] => 11995862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 394012 [patent_doc_number] => 07297706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-20 [patent_title] => 'Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders' [patent_app_type] => utility [patent_app_number] => 11/456589 [patent_app_country] => US [patent_app_date] => 2006-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14070 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/297/07297706.pdf [firstpage_image] =>[orig_patent_app_number] => 11456589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102427 [patent_doc_number] => 07728024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Metal salts of 2′-(1H-Tetrazol-5yl)-1.1′-biphenyl-4-carboxaldehyde' [patent_app_type] => utility [patent_app_number] => 11/995240 [patent_app_country] => US [patent_app_date] => 2006-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4322 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/728/07728024.pdf [firstpage_image] =>[orig_patent_app_number] => 11995240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 123585 [patent_doc_number] => 07705159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Process for the preparation of letrozole' [patent_app_type] => utility [patent_app_number] => 11/482228 [patent_app_country] => US [patent_app_date] => 2006-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7326 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705159.pdf [firstpage_image] =>[orig_patent_app_number] => 11482228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5540013 [patent_doc_number] => 20090221818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Inhibitors of Fibroblast Activation Protein Alpha' [patent_app_type] => utility [patent_app_number] => 11/994707 [patent_app_country] => US [patent_app_date] => 2006-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8107 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221818.pdf [firstpage_image] =>[orig_patent_app_number] => 11994707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314889 [patent_doc_number] => 07524859 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => '(2-carboxamido)(3-amino)thiophene compounds' [patent_app_type] => utility [patent_app_number] => 11/476952 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11500 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524859.pdf [firstpage_image] =>[orig_patent_app_number] => 11476952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552789 [patent_doc_number] => 20090286775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Bicyclic Derivatives as P38 Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/993261 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20831 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286775.pdf [firstpage_image] =>[orig_patent_app_number] => 11993261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820579 [patent_doc_number] => 07407910 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Ligands for asymmetric reactions' [patent_app_type] => utility [patent_app_number] => 11/473035 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16075 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/407/07407910.pdf [firstpage_image] =>[orig_patent_app_number] => 11473035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693929 [patent_doc_number] => 20070015757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Novel Glucagon Antagonists/Inverse Agonists' [patent_app_type] => utility [patent_app_number] => 11/424871 [patent_app_country] => US [patent_app_date] => 2006-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16093 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015757.pdf [firstpage_image] =>[orig_patent_app_number] => 11424871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 190968 [patent_doc_number] => 07642279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-05 [patent_title] => 'Atipamezole hydrochloride crystallization method' [patent_app_type] => utility [patent_app_number] => 11/913776 [patent_app_country] => US [patent_app_date] => 2006-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1223 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/642/07642279.pdf [firstpage_image] =>[orig_patent_app_number] => 11913776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13815 [patent_doc_number] => 07807698 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Azabicyclo[3.1.0]hexane derivatives as modulators of the dopamine D3 receptor' [patent_app_type] => utility [patent_app_number] => 11/917355 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11718 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807698.pdf [firstpage_image] =>[orig_patent_app_number] => 11917355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4573174 [patent_doc_number] => 07829588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Modulators of the PPAR-type receptors and pharmaceutical/cosmetic applications thereof' [patent_app_type] => utility [patent_app_number] => 11/450392 [patent_app_country] => US [patent_app_date] => 2006-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13623 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829588.pdf [firstpage_image] =>[orig_patent_app_number] => 11450392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6571922 [patent_doc_number] => 20100234615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Process for the synthesis of triazoles' [patent_app_type] => utility [patent_app_number] => 11/921838 [patent_app_country] => US [patent_app_date] => 2006-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26861 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234615.pdf [firstpage_image] =>[orig_patent_app_number] => 11921838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474429 [patent_doc_number] => 20090247595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Process for the preparation of tetrazolyl compounds' [patent_app_type] => utility [patent_app_number] => 11/921677 [patent_app_country] => US [patent_app_date] => 2006-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6943 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247595.pdf [firstpage_image] =>[orig_patent_app_number] => 11921677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122239 [patent_doc_number] => 07709655 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Clickphosphines for transition metal-catalyzed reactions' [patent_app_type] => utility [patent_app_number] => 11/445464 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6572 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709655.pdf [firstpage_image] =>[orig_patent_app_number] => 11445464 [rel_patent_id] =>[rel_patent_doc_number] =>)